UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;KEROS THERAPEUTICS
发明人:
BETHUNE, Sarah,DIAZ, Krista,EVANS, Catherine, A.,ALIMARDANOV, Asaf,HUANG, Junfeng,SEEHRA, Jasbir,LACHEY, Jennifer
申请号：
USUS2019/058062
公开号：
WO2020/086963A1
申请日:
2019.10.25
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to crystalline forms of an ALK2 inhibitor, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to pharmaceutical uses of the crystalline forms.L'invention concerne des formes cristallines d'un inhibiteur d'ALK2, des procédés de préparation de celles-ci, et des préparations pharmaceutiques associées de celles-ci. L'invention concerne également des utilisations pharmaceutiques des formes cristallines.
